Answers are grounded in this paper and cite their sources.
This paper reports a preliminary laboratory evaluation of a low-cost stair-climbing wheelchair prototype and identifies the mechanical limits that govern its failures under load on a representative Egyptian residential staircase. The prototype, a smart stair-climbing wheelchair (SCW), combines a rear motorized stair-tread mechanism actuated by two 12 V linear actuators, differential-drive 24 V brushless hub motors, and a NodeMCU ESP8266 control and IoT layer providing Blynk-based remote override, GPS tracking and infrared obstacle detection for level-ground driving. Analytical models of actuator kinematics, actuator force, drive torque, power budget, traction and static stability were developed and compared with measurements. On a five-step laboratory staircase (riser 175 mm, tread 275 mm, pitch 32.5°), the prototype completed 10 of 10 unloaded ascents (100%; exact 95% CI 69–100%) and 7 of 10 ascents with a 70 kg dead-weight load (70%; 95% CI 35–93%). All loaded failures occurred at the terminal-step transition; tread slip was the recorded failure mode in all three cases, and the models attribute it to a combination of insufficient drive-torque margin (≈ 83 N·m demand per motor versus a 45 N·m continuous and an 85 N·m peak rating) and marginal tread traction (required friction coefficient 0.64 versus ≈ 0.65 available). For the 100 kg design payload (130 kg total mass) the models predict ≈ 106 N·m per motor, above the peak rating, and an actuator safety factor of only 1.33, and the preliminary static-stability estimate indicates that the chair is not self-stable on the flight without attendant support. The measured actuator extension (92 ± 3 mm) and the current-based peak torque estimate (83 N·m) were consistent with the model predictions within 5%. The IoT layer achieved a mean remote-command latency of 180 ms, an obstacle-stop latency of 45 ms and a GPS accuracy of 2.5–3.5 m, at a prototype component cost of USD 350–450. The results demonstrate the feasibility of the low-cost architecture but not yet its reliability for users; specific design corrections and a validation plan are proposed. No human participants were involved, and the findings do not constitute clinical validation.
No takes yet. Share an insight, caveat, or question.
Elgamal et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: